Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Biochemical Assay for Inhibitors of CK2α Kinase Activity Assay from US Patent US11866436: "Benzo[c][2,6]naphthyridine derivatives, compositions and therapeutic uses thereof"
Assay data:181 Active, 118 Activity ≤ 1 nM, 181 Activity ≤ 1 µM, 181 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMRelated BioAssays by DepositorRelated BioAssays by Target
Radiometric Kinase Assay from US Patent US20230278983: "INDOLE DERIVATIVES AND USES THEREOF FOR TREATING A CANCER"
Assay data:85 Active, 71 Activity ≤ 1 µM, 90 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMRelated BioAssays by Target
CK2 Assay (20 uM ATP) from US Patent US8168651: "Protein kinase modulators"
Assay data:52 Active, 44 Activity ≤ 1 µM, 53 Tested
CK2 Assay (15 uM ATP) from US Patent US8168651: "Protein kinase modulators"
Assay data:179 Active, 197 Activity ≤ 1 µM, 200 Tested
CK2 Assay from US Patent US8168651: "Protein kinase modulators"
Assay data:35 Active, 23 Activity ≤ 1 µM, 64 Tested
Inhibition of CK2alpha (unknown origin) relative to control
Assay data:3 Tested
SummaryPubMed CitationRelated BioAssays by Target
Inhibition of human recombinant GST-tagged CK-2 using RRRADDSDDDDD as substrate incubated for 5 mins by scintillation counter analysis
Assay data:4 Active, 2 Activity ≤ 1 µM, 4 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMPubMed CitationRelated BioAssays by Target
Selectivity interaction (Kinase panel (Eurofins)) EUB0000320b CSNK2A2
Assay data:1 Tested
SummaryRelated BioAssays by Target
Selectivity interaction (Kinase panel (University of Dundee)) EUB0000169b CSNK2A1
Selectivity interaction (KinomeScan (DiscoverX)) EUB0000702a CSNK2A2
Selectivity interaction (Kinase panel (radiometric kinase assay)) EUB0000677a CSNK2A1
Assay data:1 Active, 1 Activity ≤ 1 µM, 1 Tested
Affinity Biochemical interaction (Radiometric activity assay (15 M ATP)) EUB0000613a CSNK2A1
Assay data:1 Active, 1 Activity ≤ 1 nM, 1 Activity ≤ 1 µM, 1 Tested
Affinity Phenotypic Cellular interaction (Endogenous CK2 activity in Jurkat cells) EUB0000613a CSNK2A1
Thermal Shift Assay. Domain: start/stop: M1-P335
Assay data:27 Tested
Thermal Shift Assay. Domain: start/stop: M1-S337
Inhibition of CK2alpha1(unknown origin) transfected in HEK293T cells using NanoBRET NanoGlo as substrate incubated for 2 hrs by NanoBRET assay
Inhibition of human CK2alpha1 using RRRDDDSDDD peptide as substrate in presence of [gamma-33P]ATP by radiometric based scintillation proximity assay
Binding affinity to wild type full length human CK2alpha1 (1 to 391 residues) expressed in mammalian expression system assessed as change in melting temperature at 10 uM by SYPRO orange dye based DSF assay
Assay data:7 Tested
Inhibition of human CK-2 at 10 uM by radiometric kinase activity assay relative to control
Inhibition of human CK-2 at 0.1 uM by radiometric kinase activity assay relative to control
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on